Five Purdue Pharma LP patents covering an abuse-resistant OxyContin formulation that reduces the opiod’s toxicity are invalid ...

As the U.S. opioid crisis deepened, Medicare plans administered by UnitedHealth and CVS Health were a top source of OxyContin ...

McKinsey & Company consulting firm has agreed to pay $650 million to settle a federal investigation into its work to help ...

Here’s a look at the opioid crisis. Experts say the United States is in the throes of an opioid epidemic. An estimated 8.9 million Americans aged 12 and older misused opioids in 2023. Opioids are ...

McKinsey & Company agreed to pay $650 million in a deferred prosecution agreement that will resolve a federal criminal probe ...

Wellpath, a health care provider for hospitals, prisons and jails, has been dogged by wrongful death and medical negligence ...

McKinsey & Company agreed to pay $650 million in a deferred prosecution agreement that will resolve a federal criminal probe into the company’s consulting work advising Purdue Pharma on how ...

Potential legal and legislative battles are sure to dominate Johnson & Johnson’s talcum powder litigation in 2025.

Global consulting firm McKinsey & Company agreed Friday to pay $650 million to resolve criminal and civil investigations into the advice it provided to opioids manufacturer Purdue Pharma.

The company "knowingly and intentionally" conspired with pharmaceutical firm Purdue Pharma to "aid and abet the misbranding of prescription drugs... without valid prescriptions", according to the ...

The author writes "This fall, the bankruptcy court extended the preliminary injunction for the thirty-seventh time and ...